Cheryl Squier

5.6k total citations · 1 hit paper
23 papers, 4.4k citations indexed

About

Cheryl Squier is a scholar working on Infectious Diseases, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Cheryl Squier has authored 23 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Cheryl Squier's work include Antimicrobial Resistance in Staphylococcus (6 papers), HIV/AIDS Research and Interventions (6 papers) and Nosocomial Infections in ICU (4 papers). Cheryl Squier is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), HIV/AIDS Research and Interventions (6 papers) and Nosocomial Infections in ICU (4 papers). Cheryl Squier collaborates with scholars based in United States and Australia. Cheryl Squier's co-authors include Marilyn M. Wagener, Nina Singh, Susan Swindells, David L. Paterson, Emanuel N. Vergis, Victor L. Yu, N. Singh, M. Hong Nguyen, M Wagener and Stephen Berman and has published in prestigious journals such as Annals of Internal Medicine, Clinical Infectious Diseases and Transplantation.

In The Last Decade

Cheryl Squier

23 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection

2000 2.7k citations David L. Paterson, Susan Swindells et al. Annals of Internal Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl Squier United States	19	3.7k	1.3k	1.2k	797	758	23	4.4k
Emanuel N. Vergis United States	16	3.2k 0.9×	1.2k 0.9×	1.3k 1.1×	639 0.8×	578 0.8×	25	4.0k
Rita Murri Italy	40	3.1k 0.8×	1.5k 1.2×	1.4k 1.2×	1.0k 1.3×	448 0.6×	153	5.0k
Nina Singh United States	37	4.9k 1.3×	1.2k 0.9×	3.6k 3.0×	822 1.0×	688 0.9×	76	7.3k
Andrew H. Kaplan United States	20	1.7k 0.5×	511 0.4×	830 0.7×	279 0.4×	568 0.7×	29	2.5k
Hernando Knobel Spain	38	2.7k 0.7×	1.5k 1.2×	1.2k 1.0×	1.5k 1.9×	242 0.3×	183	5.1k
Paul J. Weidle United States	32	2.8k 0.8×	1.1k 0.9×	1.5k 1.2×	483 0.6×	644 0.8×	95	3.5k
Sonia Napravnik United States	36	2.6k 0.7×	1.2k 0.9×	1.6k 1.3×	933 1.2×	617 0.8×	173	4.1k
Gregory M. Lucas United States	41	4.5k 1.2×	1.6k 1.3×	3.1k 2.5×	1.5k 1.9×	538 0.7×	149	6.1k
François Raffi France	40	5.1k 1.4×	3.6k 2.8×	1.4k 1.2×	1.4k 1.8×	258 0.3×	208	6.3k
Susan E. Cohn United States	33	2.3k 0.6×	647 0.5×	1.3k 1.1×	660 0.8×	791 1.0×	111	3.3k

Countries citing papers authored by Cheryl Squier

Since Specialization

Citations

This map shows the geographic impact of Cheryl Squier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Squier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Squier more than expected).

Fields of papers citing papers by Cheryl Squier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Squier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Squier. The network helps show where Cheryl Squier may publish in the future.

Co-authorship network of co-authors of Cheryl Squier

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Squier. A scholar is included among the top collaborators of Cheryl Squier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Squier. Cheryl Squier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Ellingson, Katherine, Robert R. Muder, Rajiv Jain, et al.. (2010). Sustained Reduction in the Clinical Incidence of Methicillin-Resistant Staphylococcus aureus Colonization or Infection Associated with a Multifaceted Infection Control Intervention. Infection Control and Hospital Epidemiology. 32(1). 1–8. 56 indexed citations

2.

Muder, Robert R., et al.. (2008). Implementation of an Industrial Systems-Engineering Approach to Reduce the Incidence of Methicillin-ResistantStaphylococcus aureusInfection. Infection Control and Hospital Epidemiology. 29(8). 702–708. 50 indexed citations

3.

Aspinall, Sherrie L., et al.. (2008). Evaluation of Clostridium difficile-Associated Diarrhea With a Drug Formulary Change in Preferred Fluoroquinolones. Journal of Managed Care Pharmacy. 14(1). 34–40. 17 indexed citations

4.

Singh, Nina, Cheryl Squier, Cheryl Wannstedt, et al.. (2006). Impact of an Aggressive Infection Control Strategy on Endemic Staphylococcus aureus Infection in Liver Transplant Recipients. Infection Control and Hospital Epidemiology. 27(2). 122–126. 55 indexed citations

5.

Squier, Cheryl, et al.. (2005). A proactive approach to prevention of health care–acquired Legionnaires' disease: The Allegheny County (Pittsburgh) experience. American Journal of Infection Control. 33(6). 360–367. 25 indexed citations

6.

Squier, Cheryl, Angella Goetz, Marilyn M. Wagener, & Robert R. Muder. (2004). The anergy panel: An ineffective tool to validate tuberculin skin testing. American Journal of Infection Control. 32(4). 243–245. 2 indexed citations

7.

Paterson, David L., et al.. (2003). Lack of efficacy of mupirocin in the prevention of infections with staphylococcus aureus in liver transplant recipients and candidates1. Transplantation. 75(2). 194–198. 44 indexed citations

8.

Squier, Cheryl, John D. Rihs, Marilyn M. Wagener, et al.. (2002). Staphylococcus AureusRectal Carriage and its Association with Infections in Patients in a Surgical Intensive Care Unit and a Liver Transplant Unit. Infection Control and Hospital Epidemiology. 23(9). 495–501. 92 indexed citations

9.

Squier, Cheryl & Robert R. Muder. (2002). Saunders Infection Control Reference Service: The Experts' Guide to the Guidelines, 2nd ed. E Abrutyn, DA Goldmann, and WE Scheckler, eds.; Philadelphia: W. B. Saunders, 2000; 1,310 pages. Infection Control and Hospital Epidemiology. 23(6). 349–349. 5 indexed citations

10.

Paterson, David L., et al.. (2001). Control of an Outbreak of Infection Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coliin a Liver Transplantation Unit. Clinical Infectious Diseases. 33(1). 126–128. 58 indexed citations

11.

Singh, N., David L. Paterson, F. Y. Chang, et al.. (2000). Methicillin-Resistant Staphylococcus aureus: The Other Emerging Resistant Gram-Positive Coccus among Liver Transplant Recipients. Clinical Infectious Diseases. 30(2). 322–327. 108 indexed citations

12.

Paterson, David L., Susan Swindells, Emanuel N. Vergis, et al.. (2000). Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV Infection. Annals of Internal Medicine. 133(1). 21–30. 2678 indexed citations breakdown →

13.

Singh, Nina, et al.. (1999). Adherence of Human Immunodeficiency Virus–Infected Patients to Antiretroviral Therapy. Clinical Infectious Diseases. 29(4). 824–830. 226 indexed citations

14.

Swindells, Susan, et al.. (1999). Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. International Journal of STD & AIDS. 10(6). 383–391. 187 indexed citations

15.

Swindells, Susan, et al.. (1999). Quality of life in patients with human immunodeficiency virus infection: impact of social support, coping style and hopelessness. International Journal of STD & AIDS. 10(6). 383–391. 80 indexed citations

16.

Squier, Cheryl, et al.. (1997). Psychological stress and depression in older patients with intravenous drug use and human immunodeficiency virus infection: implications for intervention. International Journal of STD & AIDS. 8(4). 251–255. 28 indexed citations

17.

Jm, Miller, et al.. (1996). Reduction in nosocomial intravenous device-related bacteremias after institution of an intravenous therapy team.. PubMed. 19(2). 103–6. 29 indexed citations

18.

Singh, N., et al.. (1996). Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: Prospective assessment with implications for enhancing compliance. AIDS Care. 8(3). 261–270. 430 indexed citations

19.

Singh, Nina, et al.. (1996). Determinants of nontraditional therapy use in patients with HIV infection. A prospective study.. PubMed. 156(2). 197–201. 57 indexed citations

20.

Goetz, Angella, et al.. (1994). Nowosocomial infections in the human immunodeficiency virus-infected patient: A two-year survey. American Journal of Infection Control. 22(6). 334–339. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact